Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02946463
Brief Title: ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

First Submitted : October 25, 2016
First Submitted that Met QC Criteria : October 25, 2016
First Posted : October 27, 2016 (Estimate)

Results First Submitted : January 24, 2019
Results First Submitted that Met QC Criteria : January 24, 2019
Results First Posted : February 12, 2019

Last Update Submitted that Met QC Criteria : May 13, 2020
Last Update Posted : May 15, 2020